Visiongain publishes Breath Analyzers Market Report 2020-2030

20 February 2020
Pharma

Visiongain has launched a new pharma report Breath Analyzers Market Report 2020-2030: Prospects by Technology (Fuel Cell Technology, Semiconductor Oxide Sensor Technology, Other Technologies (Infrared Breathalyzers, Chemical Crystal Technology)), Applications (Alcohol Detection, Drug Abuse Detection, Medical Applications (Tuberculosis Detection, Asthma Detection, Others)), End Users (Law Enforcement Agencies, Enterprises, Individuals), and Geography.

The global breath analyzers market is projected to grow at a lucrative CAGR of ~26% and anticipated to surpass USD xx billion by 2030.

The breath analyzers are medical devices used to identify different compounds from an individual's exhaled breath. The breath analyzer is mostly used to detect blood alcohol content but it can also be used to detect respiratory system-related diseases like pneumonia, asthma, and other diseases. Nevertheless, the blood alcohol content cannot be measured directly, and further analysis of the blood sample is necessary.

The increasing road accidents caused by excessive alcohol consumption and the laws enforced to prevent these things allow the use of breath analyzers by law enforcement agencies or by individuals themselves. Breath analyzers can be used in various areas, such as by traffic police to detect alcohol consumption during driving, by professionals to restrict a drunk person from entering the premises of the company or any other social sites, or they can be used in medical emergencies where many patients are under the influence of alcohol that can cause a diagnostic problem.

The primary factor for the growth of the global market for breath analyzers is increasing awareness and the government's implementation of strict rules for drink and drive cases. Rise in the market for breath analyzers is largely due to increased alcohol consumption, drug abuse, and a rise in the prevalence of diseases such as tuberculosis, asthma, and other diseases.

Governments in specific nations have set a legal limit for alcohol content in blood while testing as well as have increased breath testing activities. The rising usage of breath analyzers in medical applications is also anticipated to fuel the breath analyzers market. However, the lower accuracy of some products might challenge the global breath analyzer market growth.

Breath monitoring devices are commonly used by law enforcement agencies to enhance road traffic safety. There is an increasing awareness in workplaces and legal requirements to keep the workforce drug-and alcohol-free. As a result, demand from offices, workplaces, and schools has increased. Hence the market is anticipated to grow over the forecast period.

However, breath analyzers are highly susceptible to external factors such as temperature & drugs which might restrain the market growth. Nevertheless, it is expected that the introduction of advanced devices designed to reduce these issues will fuel market growth over the forecast period.

The use of fuel cell technology has shown significant growth in breath analyzers. Instances of a misreading of acetone & ketone in breath have been significantly reduced due to the alcohol sensitivity of the fuel cell technology. Fuel cell technology has become a gold standard for handheld devices owing to the advantages such as portability and minimum power requirements. It is expected that the demand for compact and user-friendly analyzers will provide room for market growth over the forecast period.

In the year 2018, North America dominated the global breath analyzers market owing to high adaptation rates and awareness of road safety. The North American market is anticipated to continue its dominance over the forecast period owing to the rise in easy product approval procedures.

During the forecast period, Asia Pacific is anticipated to witness the fastest growth. China, Japan, India, Malaysia, & Australia are the major markets in the region. In these countries, the use of breath analyzers is still limited due to law enforcement departments. Untapped regions as mentioned above are anticipated to offer tremendous opportunities for growth over the forecast period.

Some of the major players operating in this industry are Abbott, AK GlobalTech Corporation, Akers Biosciences, Inc., Alcohol Countermeasure Systems Corporation, Alcolisor, Alere, Inc., BACtrack, Inc., Drägerwerk AG & Co. KGaA, EnviteC-Wismar GmbH, Intoximeters, Inc., KHN Solutions LLC Bactrack Breathalyzers, Lifeloc Technologies, Mpd, Inc., Quest Products, Inc., Thermo Fisher Scientific, TruTouch among other prominent players.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

Read

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

Read

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

Read

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever